Skip to main content
Caplight Logo









Emanate

Emanate

Private
San Francisco, CaliforniaEnterprise Softwarehttps://emanate.ai

Last Round

Seed

Feb 9, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Emanate operates in Enterprise Software and is based in San Francisco, California. Its latest recorded funding round was a Seed round in February 2026.

Emanate is an artificial intelligence company that provides an AI revenue engine built for industrial growth, using autonomous AI to execute revenue operations.

Sector

Enterprise Software

Verticals

Vertical SaaS, Sales Enablement, Workflow Automation, NLP & Conversational AI, Smart Manufacturing

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Emanate Comparables

Compare Emanate with similar companies based on industry and business-model similarity.

Emanate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Forgepoint
87%
Uptool
84%
Distro
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Emanate Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 9, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Emanate Investors

Notable investors and investment history

Emanate investors
InvestorRounds
Andreessen HorowitzSeed
M13Seed
GaingelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 51% MoM, reaching 7.8K.

  • Jul 22, 2026

    Grew 300% QoQ from 1 to 4 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Emanate Filings

Explore SEC and related filing metadata, where available.

Emanate filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Emanate's valuation, stock price, and market status.

Is Emanate a public or private company?

Emanate is a private company.

What is the current stock price of Emanate?

Emanate is a private company, so its shares have no public market price. Caplight tracks Emanate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Emanate worth (valuation)?

Valuation information for Emanate is not publicly available.

Can I buy Emanate stock?

Emanate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Emanate's last funding round?

Emanate's most recent funding round was Seed on February 9, 2026.

Who are the main investors in Emanate?

Key investors in Emanate include Andreessen Horowitz.

Will Emanate IPO soon?

No public IPO plans have been announced for Emanate.

How can I track Emanate secondary market activity?

Caplight tracks bids, offers, and trades in Emanate's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range4
Year Founded2026
Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?